Design, synthesis and evaluation of the Brigatinib analogues as potent inhibitors against tertiary EGFR mutants (EGFRdel19/T790M/C797S and EGFRL858R/T790M/C797S).
Bioorganic & medicinal chemistry letters | 2022-09-15 | PMID 35413415
Fang Haotian, Wu Yingming, Xiao Qitao and 5 more
